About
About

We are a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases.
About Us

Leadership

Board of Directors

PCA Regenerative Medicine Advisory Board

Clinical Advisory Board
Our Science
Our Science

Our PCA approach may represent a transformative step in the evolution of regenerative medicine, reducing complexity by temporarily reactivate progenitor cells already located at the tissue target site – and pre-programmed to make specific cell types.
PCA Approach

Therapeutic Discovery Process

Publications
Pipeline & Programs
Pipeline & Programs

Naturally repairing or reversing damage caused by degenerative disease
Pipeline

Hearing Program

Multiple Sclerosis Program

Strategic Partnerships
About Hearing Loss
Investors & Media
Investors & Media
Overview

Corporate Governance

Press Releases

Events & Presentations

Stock Information

SEC Filings

Annual Reports and Proxy Statements

Investor FAQ

Investor & Media Contacts

Events and Presentations

Events and Presentations

Upcoming Events

Archived Events

Mar 2 12:00 PM EST

40th Annual Cowen Healthcare Conference, Q&A Session

Location

Boston Marriott Copley Place, Exeter Room
Mar 2 11:20 AM EST

40th Annual Cowen Healthcare Conference

The presentation will be webcast live.

Click here for webcast

Location

Boston Marriott Copley Place, Dartmouth room